Alterity Therapeutics (ATH)
83.33
0.00 (0.00%)
Upcoming Events
Latest Headlines
Cenovus tumbles as C$5.7 billion Athabasca deal raises debt concerns
October 5, 2026 10:33 AM - StreetInsider
Cenovus stock falls as company announces $5.7B Athabasca deal
October 5, 2026 9:05 AM - StreetInsider
Cenovus Energy to acquire Athabasca Oil for $12 per share
October 5, 2026 6:00 AM - StreetInsider
Cenovus to acquire Athabasca Oil in a $5.7B deal
October 5, 2026 6:00 AM - StreetInsider
Athabasca Oil Announces Agreement to be Acquired by Cenovus Energy
October 5, 2026 6:00 AM - Globe NewsWire
Cenovus announces agreement to acquire Athabasca Oil Corporation
October 5, 2026 6:00 AM - StreetInsider
Parties in the Matter of Athene Holding Ltd v Imran Siddiqui Announce Settlement
September 18, 2026 8:30 AM - Globe NewsWire
Athene prices $1B in senior notes due 2036
August 5, 2026 8:13 PM - StreetInsider
Athene Prices $1,000,000,000 Investment Grade Senior Notes Offering
August 5, 2026 8:13 PM - Globe NewsWire
Athene Holding Ltd. Declares Third Quarter 2026 Preferred Stock Dividends
August 3, 2026 4:30 PM - Globe NewsWire
Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update
July 30, 2026 7:25 AM - Globe NewsWire
Athabasca Oil posts Q2 results as Leismer expansion advances
July 29, 2026 8:13 PM - StreetInsider
Athabasca Oil Reports 2026 Second Quarter Results Highlighted by Leismer Expansion Milestones and Advancement of Corner Phase 1
July 29, 2026 8:12 PM - Globe NewsWire
Full Article List
